http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0012677-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c3d76288892ddbddca3e1fe2313ec5c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08 |
| filingDate | 1999-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da21e24b5409ec266359f450064f37df |
| publicationDate | 2000-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0012677-A2 |
| titleOfInvention | Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines |
| abstract | The invention relates to the generation and mutagenesis of recombinant infectious bursal disease virus by reverse genetics technology. Site-directed mutagenesis of certain amino acid residues on the Non-CEF adapted, very virulent strains of IBDV transforms the viruses into attenuated, CEF-adapted strains. The attenuated, CEF-adapted strains can be used as live vaccines against the very virulent strains. Curently available live attenuated vaccines were generated by serial passage through cell culture and the like, whereas the present invention provides a novel molecular mechanism in manipulation of the viral genome and the generation of attenuated vaccines by site-directed mutagenesis. The same approach can be used to produce vaccine strains from newly evolved IBDV viruses or to manipulate the antigenicity and pathogenicity of the virus. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102258777-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1170302-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007526215-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6485940-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620504-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1689858-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1689858-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3620505-A1 |
| priorityDate | 1998-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.